Meridan ReportLondon: European finance and fintech intelligence

66°F · Mostly Clear

Advertisement

Health

The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

Managing Editor · Friday, October 23, 2026 at 6:58 PM · 1 min read

The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term. — MarketWatch, London Health news — Image: MarketWatch

The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.

Up nextMyanmar's detained leader Suu Kyi traded health concerns with her son in their first call in 5 yearsHealth · 1 min read

More Health stories

Myanmar's detained leader Suu Kyi traded health concerns with her son in their first call in 5 years — WPLG Local 10

Myanmar's detained leader Suu Kyi traded health concerns with her son in their first call in 5 years

By Katherine Langford

WPLG Local 10

Novartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib — KFGO

Novartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib

By Marcus Chen

KFGO

‘Taken far too soon:’ Family remembers Hunter Russey after police say business owner hits, kills teen in West Melbourne — ClickOrlando Local

‘Taken far too soon:’ Family remembers Hunter Russey after police say business owner hits, kills teen in West Melbourne

By Marcus Chen

ClickOrlando Local

My spouse was awarded $90,000 from my 401(k) in our divorce. How is that fair? — MarketWatch

My spouse was awarded $90,000 from my 401(k) in our divorce. How is that fair?

By Katherine Langford

MarketWatch